La FDA aprueba el primer producto biosimilar de insulina de acción rápida para el tratamiento de la diabetes.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761325Orig1s000lbl.pdf?utm_medium=email&utm_source=govdelivery FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes Agency Continues Efforts to Increase Access to Insulin Treatment Options https://www.fda.gov/news-events/press-announcements/fda-approves-first-rapid-acting-insulin-biosimilar-product-treatment-diabetes?utm_medium=email&utm_source=govdelivery